Analyst Ratings For Deciphera Pharmaceuticals (NASDAQ:DCPH)
Today, B. Riley initiated coverage on Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Buy with a price target of $43.00.
Some recent analyst ratings include
- 2/16/2018-B. Riley initiated coverage with a Buy rating.
- 10/23/2017-Nomura initiated coverage with a Buy rating.
- 10/23/2017-Piper Jaffray Companies initiated coverage with a Overweight rating.
- 10/23/2017-Instinet initiated coverage with a Buy rating.
- 10/23/2017-JMP Securities initiated coverage with a Mkt Outperform rating.
- 10/23/2017-JPMorgan Chase & Co. initiated coverage with a Overweight rating.
- On 10/2/2017 New Leaf Venture Management Ii, Major Shareholder, bought 375,000 with an average share price of $17.00 per share and the total transaction amounting to $6,375,000.00.
Recent Trading Activity for Deciphera Pharmaceuticals (NASDAQ:DCPH)
Shares of Deciphera Pharmaceuticals closed the previous trading session at 29.25 up +0.55 1.92% with 29.200000762939453 shares trading hands.
